Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Stewart Information Services
STC
$2.04B
| $20.2M | 0.01% |
319,501
+8,681
| +3% | +$517K |
|
1577
Medifast
MED
$131M
| $20.2M | 0.01% |
104,714
-2,241
| -2% | -$551K |
|
1578
Universal Corp
UVV
$1.15B
| $20.2M | 0.01% |
417,357
+25,840
| +7% | +$1.31M |
|
1579
Blue Owl Capital
OWL
$19.2B
| $20.2M | 0.01% |
+1,295,939
| New | +$18M |
|
1580
Hamilton Lane
HLNE
$5.78B
| $20.1M | 0.01% |
236,727
+9,542
| +4% | +$854K |
|
1581
Worthington Enterprises
WOR
$2.81B
| $20.1M | 0.01% |
617,899
-11,419
| -2% | -$412K |
|
1582
Gibraltar Industries
ROCK
$1.47B
| $20.1M | 0.01% |
288,195
+11,590
| +4% | +$834K |
|
|
CVET
1583
DELISTED
Covetrus, Inc. Common Stock
CVET
| $20.1M | 0.01% |
1,105,695
+29,963
| +3% | +$687K |
|
1584
Ligand Pharmaceuticals
LGND
$5.76B
| $20M | 0.01% |
230,444
+10,556
| +5% | +$816K |
|
1585
Newmark Group
NMRK
$2.73B
| $20M | 0.01% |
1,399,239
-40,724
| -3% | -$525K |
|
1586
Goosehead Insurance
GSHD
$2.34B
| $20M | 0.01% |
131,332
+13,380
| +11% | +$1.8M |
|
|
FMBI
1587
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $20M | 0.01% |
1,050,434
+25,453
| +2% | +$469K |
|
1588
Warner Music
WMG
$13.1B
| $20M | 0.01% |
467,134
+17,686
| +4% | +$672K |
|
1589
WSFS Financial
WSFS
$4.18B
| $20M | 0.01% |
388,958
+5,683
| +1% | +$256K |
|
|
IRBT
1590
DELISTED
iRobot
IRBT
| $19.9M | 0.01% |
254,009
+9,336
| +4% | +$795K |
|
1591
Trustmark
TRMK
$2.82B
| $19.9M | 0.01% |
616,742
-44,572
| -7% | -$1.37M |
|
1592
Vicor
VICR
$10.7B
| $19.9M | 0.01% |
148,082
+1,550
| +1% | +$185K |
|
1593
Xerox
XRX
$414M
| $19.8M | 0.01% |
983,854
-494,797
| -33% | -$11.2M |
|
1594
Kadant
KAI
$3.9B
| $19.8M | 0.01% |
97,162
+1,104
| +1% | +$218K |
|
|
TWNK
1595
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $19.8M | 0.01% |
1,137,623
+28,805
| +3% | +$466K |
|
1596
Designer Brands
DBI
$312M
| $19.8M | 0.01% |
1,417,709
-144,040
| -9% | -$2.08M |
|
1597
Madison Square Garden
MSGS
$10.4B
| $19.6M | 0.01% |
105,667
-36,795
| -26% | -$6.3M |
|
|
CMRC
1598
Commerce.com Inc Series 1
CMRC
$181M
| $19.6M | 0.01% |
387,914
+228,683
| +144% | +$13.9M |
|
1599
O-I Glass
OI
$1.06B
| $19.6M | 0.01% |
1,373,899
+10,079
| +0.7% | +$151K |
|
1600
Kaiser Aluminum
KALU
$3.04B
| $19.6M | 0.01% |
179,901
-3,128
| -2% | -$373K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.